Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q1 2014 · 10-Q
Revenue$0.00$0.00— vs Q1 2013 Net Income$3.96M$3.96MN/M vs Q1 2013 EPS Diluted$0.03$0.03N/M vs Q1 2013 Operating Income-$778,757N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 14, 2014 · 44 d after period end